Zymeworks Inc. ZYME 深 滬
等待開盤 09-09 09:30:00 美东时间
15.19
+0.140
+0.93%
華盛通- 最 高15.515
- 今 開15.00
- 成交量 50.88万股
- 最 低 14.69
- 昨 收 15.05
- 總市值 10.58亿
- 52周最高 17.70
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 9.03
- 委 比 68.75%
- 總股本 6968.35万
- 歷史最高 59.03
- 量 比 0.94
- 振 幅 5.48%
- 歷史最低 4.11
- 每 手 1
- 風險率 1.28%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Zymeworks down after dropping anticancer agent
Zymeworks (NASDAQ:ZYME) shares dropped in the morning hours on Tuesday after the company announced plans to discontinue further clinical studies for its anticancer agent ZW171 following unsatisfactory...
09-02 21:56
Zymeworks shares are trading lower after the company discontinued clinical development of ZW171.
Zymeworks shares are trading lower after the company discontinued clinical deve...
09-02 20:54
百济神州市值突破5000亿元，成A股“药王”靠什么支撑？
9月2日，百济神州（688235.SH）A股股价单日大涨9.84%，市值突破5074亿元，登顶A股医药股市值榜首。盘中涨幅一度超过15%，股价创下346元/股的...
09-02 19:01
【天风医药杨松团队|公司点评】百济神州：2025 Q2 利润端大幅超预期，连续两季度 GAAP 利润为正
（来源：一棵大松树） 公司发布2025年半年度主要财务数据，2025H1总收入24.33亿美元，同比增长45%；GAAP净利润和经调整后净利润分...
08-27 12:59
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers OSR Holdings (NASDAQ:OSRH) shares rose 34.6% to $0.7 during Friday's a...
08-23 05:07
Zymeworks Announces Participation in Upcoming Investor Conferences
Zymeworks Inc. announced that its management will participate in several upcoming investor conferences in September 2025. These include one-on-one meetings and fireside chats at the Citi’s Biopharma Back to School Conference on September 3 in Boston, the Wells Fargo Healthcare Conference on September 4, the Cantor Global Healthcare Conference on September 5, and the Morgan Stanley Annual Global Healthcare Conference on September 8. Zymeworks, a c...
08-19 10:00
Citigroup Maintains Buy on Zymeworks, Raises Price Target to $22
Citigroup analyst Yigal Nochomovitz maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $19 to $22.
08-11 21:00
Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry
Zymeworks Inc. announced the appointments of Greg Ciongoli and Robert E. Landry to its Board of Directors, effective August 10, 2025. Both will also serve on the audit committee. The company highlighted their extensive financial and strategic expertise, noting recent progress in regulatory approvals for zanidatamab and upcoming clinical data. Ciongoli brings experience in healthcare investments and corporate governance, while Landry has over 30 y...
08-11 10:00
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
